TherapeuticsMD (TXMD) Intangibles (2010 - 2026)

TherapeuticsMD (TXMD) has reported Intangibles for 17 consecutive years, with $6.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Intangibles fell 1.91% year-over-year to $6.2 million; the trailing twelve-month figure through Jun 2026 stood at $6.2 million (down 1.91% YoY), and the FY2025 full-year result was $6.2 million, down 3.06% from the prior year.
• Intangibles was little changed at $6.2 million in Q2 2026 per TXMD's latest filing, from $6.2 million in the prior quarter.
• Across five years, Intangibles topped out at $48.4 million in Q3 2022 and bottomed at $6.2 million in Q2 2026.
• Historically, Intangibles has averaged $13.7 million across 5 years, with a median of $6.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Intangibles rose 17.96% in 2022, then plunged 86.26% in 2023.
• Over 5 years, Intangibles stood at $8.5 million in 2022, then retreated by 6.7% to $8.0 million in 2023, then declined by 19.95% to $6.4 million in 2024, then slipped by 3.06% to $6.2 million in 2025, then dropped by 0.21% to $6.2 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $6.2 million, $6.2 million, and $6.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.